Difference between Morning and Evening Thyrotropin Response to Protirelin (TRH) and Prediction of Antidepressant Treatment Outcome in Major Depression

Hormones and Behavior

Volumn , Issue , 2013, Pages 85-103

  Duval, Fabrice ^a   Mokrani, Marie Claude ^a   Lopera, Felix Gonzalez ^a   Alexa, Claudia ^a   Rabia, Hassen ^a   Proudnikova, Xenia ^a   Erb, Alexis ^a  

^a Centre Hospitalier de Rouffach   (France)

Author keywords

Biomarker; Chronobiology; Depression; HPT system; Response prediction; Thyroid hormones; TRH test; TSH

Indexed keywords

EID: 84878663711     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Abulseoud, O., Sane, N., Cozzolino, A., Kiriakos, L., Mehra, V., Gitlin, M., Masseling, S., Whybrow, P., Altshuler, L.L., Mintz, J., Frye, M.A. (2007). Free T4 index and clinical outcome in patients with depression. J. Affect. Disord. 100, 271-277.
2. Alkemade, A., Unmehopa, U.A., Brouwer, J.P., Hoogendijk, W.J., Wiersinga, W.M., Swaab, D.F., Fliers, E. (2003). Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression. Mol. Psychiatry. 8, 838-839.
3. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders. (Fourth Edition, pp. 317-391) Washington, DC: American Psychiatric Press.
4. Amsterdam, J.D., Fava, M., Maislin, G., Rosenbaum, J., Hornig-Rohan, M. (1996). TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. J. Affect. Disord. 38, 165-172.
5. Atterwill, C.K., Catto, L.C., Heal, D.J., Holland, C.W., Dickens, T.A., Jones, C.A. (1989). The effects of desipramine (DMI) and electroconvulsive shock (ECS) on the function of the hypothalamo-pituitary-thyroid axis in the rat. Psychoneuroendocrinology. 14, 339-346.
6. Banki, C.M., Bissette, G., Arato, M., Nemeroff, C.B. (1988). Elevation of Immunoreactive CSF Am. J. Psychiatry. 145:1526-1531.
7. Baumgartner, A., Gräf, K.J., Kürten, I., Meinhold, H. (1988). The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects. Part II. Repeated measurements of thyroxine, free thyroxine, triiodothyronine, free triiodothyronine, and reverse triiodothyronine in patients with major depressive disorders and schizophrenia and healthy subjects. Psychiatry Res. 24, 283-305.
8. Brady, K.T., Anton, R.T. (1989). The thyroid axis and desipramine treatment in depression. Biol. Psychiatry. 15 ; 25(6), 703-709.
9. Brady, K.T., Lydiard, B., Kellner, C.H., Joffe, R., Knight Laird, L., Morton, W.A., Steele, T.E. (1994). A comparison of the effects of imipramine and fluvoxamine on the thyroid axis. Biol. Psychiatry. 36, 778-779.
10. Brink, C.B., Harvey, B.H., Brand, L. (2006). Tianeptine: A novel atypical antidepressant that may provide new insights into the biomolecular basis of depression. Recent Pat. CNS Drug Discov. 1, 29-41.
11. Brouwer, J.P., Appelhof, B.C., Peeters, R.P., Hoogendijk, W.J., Huyser, J., Schene, A.H., Tijssen, J.G., Van Dyck, R., Visser, T.J., Wiersinga, W.M., Fliers, E. (2006). Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. Eur. J. Endocrinol. 154, 819-825.
12. Campos-Barros, A., Meinhold, H., Stula, M., Müller, F., Köhler, R., Eravci, M., Putzien, O., Baumgartner, A. (1994). The influence of desipramine on thyroid hormone metabolism in rat brain. J. Pharmacol. Exp. Ther. 268, 1143-1152.
13. Carroll, B.J., Feinberg, M., Greden, J.F., Tarika, J., Albala, A.A., Haskett, R.F., James, N.M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J.P., Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch. Gen. Psychiatry. 8, 15-22.
14. Cole, D.P., Thase, M.E., Mallinger, A.G., Soares, J.C., Luther, J.F., Kupfer, D.J., Frank, E. (2002). Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am. J. Psychiatry. 159, 116-121.
15. Connolly, K.R., Thase, M.E. (2011). If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs. 71, 43-64.
16. Cooper-Kazaz, R., Apter, J.T., Cohen, R., Karagichev, L., Muhammed-Moussa, S., Grupper, D., Drori, T., Newman, M.E., Sackeim, H.A., Glaser, B., Lerer, B. (2007). Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch. Gen. Psychiatry. 64, 679-688.
17. Corruble, E., Goldberger, C., Spann, M. (2010). Relationship between TSH levels in the normal range and short-term duloxetine efficacy. J. Affect Disord. 123, 312-316.
18. Coryell, W. (2011). The search for improved antidepressant strategies: is bigger better? Am. J. Psychiatry. 168, 664-666.
19. Duval, F., Macher, J.P., Mokrani, M.C. (1990). Difference between evening and morning thyrotropin response to protirelin in major depressive episode. Arch. Gen. Psychiatry. 47, 443-448.
20. Duval, F., Mokrani, M.C., Crocq, M.A., Diep, T.S., Macher, J.P. (1992). Protirelin test results in antidepressant treatment of major depression. in Macher, J.P., Crocq, M.A. (Eds.), New prospects in psychiatry: the bio-clinical interface I (pp. 309-312). Amsterdam, The Netherlands:Elsevier.
21. Duval, F., Mokrani, M.C., Crocq, M.A., Bailey, P., Macher, J.P. (1994). Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol. Psychiatry. 35, 926-934.
22. Duval, F., Mokrani, M.C., Crocq, M.A., Jautz, M., Bailey, P.E., Diep, T.S., Macher, J.P. (1996). Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch. Gen. Psychiatry. 53, 833-840.
23. Duval, F., Mokrani, M.C., Bailey, P., Correa, H., Diep, T.S., Crocq, M.A., Macher, J.P. (1999). Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology. 24, 695-712.
24. Duval, F., Monreal, J., Mokrani, M.C., Crocq, M.A., Macher, J.P. (2002). Effect of antidepressant medication on responses to TRH and apomorphine tests in depression. Biol. Psychiatry. 51, 123.
25. Duval, F., Mokrani, M.C., Monreal-Ortiz, J.A., Fattah, S., Champeval, C., Schulz, P., Macher, J.P. (2006). Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology.31,876-888.
26. Duval, F., Mokrani, M.C., Lopera, F.G., Diep, T.S., Rabia, H., Fattah, S. (2010). Thyroid axis activity and suicidal behavior in depressed patients. Psychoneuroendocrinology. 35, 1045-1054.
27. Eker, S.S., Akkaya, C., Sarandol, A., Cangur, S., Sarandol, E., Kirli, S. (2008). Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 955-961.
28. Endicott, J., Andreasen, N., Spitzer, R.L. (1978). Family History-Research Diagnostic Criteria. NewYork: Research Assessment and Training Unit, New York State Psychiatric Institute.
29. Eravci, M., Pinna, G., Meinhold, H., Baumgartner, A. (2000). Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology. 141, 1027-1040.
30. Fliers, E., Alkemade, A., Wiersinga, W.M., Swaab, D.F. (2006). Hypothalamic thyroid hormone feedback in health and disease. Prog. Brain Res. 153,189-207.
31. Frank, E., Prien, R.F., Jarrett, R.B., Keller, M.B., Kupfer, D.J., Lavori, P.W., Rush, J., Weissman, M.M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch. Gen. Psychiatry. 48, 851-855.
32. Frye, M.A., Dunn, R.T., Gary, K.A., Kimbrell, T.A., Callahan, A.M., Luckenbaugh, D.A., Corá-Locatelli, G., Vanderham, E., Winokur, A., Post, R.M. (1999). Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biol. Psychiatry. 45:1049-1052.
33. Gambi, F., De Berardis, D., Sepede, G., Campanella, D., Galliani, N., Carano, A., La Rovere, L., Salini, G., Penna, L., Cicconetti, A., Spinella, S., Quartesan, R., Salerno, R.M., Ferro, F.M. (2005). Effect of mirtazapine on thyroid hormones in adult patients with major depression. Int. J. Immunopathol. Pharmacol. 18(4), 737-744.
34. Gendall, K.A., Joyce, P.R., Mulder, R.T., Luty, S.E. (2003). Thyroid indices and response to fluoxetine and nortriptyline in major depression. J. Psychopharmacol. 17, 431-437.
35. Ginestet, D. (1997). Efficacy of tianeptine in major depressive disorders with or without melancholia. Eur. Neuropsychopharmacol. 7, S341-345.
36. Gitlin, M., Altshuler, L.L., Frye, M.A., Suri, R., Huynh, E.L., Fairbanks, L., Bauer, M., Korenman, S. (2004). Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J. Psychiatry Neurosci. 29, 383-386.
37. Hamilton, M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23, 56-62.
38. Hollister, L.E., Davis, K.L., Berger, P.A. (1976). Pituitary response to thyrotropin-releasing hormone in depression. Arch. Gen. Psychiatry. 33, 1393-1396.
39. Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E.B., Kern, N., Künzel, H.E., Pfennig, A., Uhr, M., Holsboer, F. (2007). Combined dexamethasone/corticotropin Biol. Psychiatry. 62:47-54.
40. Jackson, I.M. (1998). The thyroid axis and depression. Thyroid. 8, 951-956.
41. Joffe, R.T., Singer, W. (1990). The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry. 23, 67-69.
42. Joffe, R.T., Lewitt, A. J. (1993). The thyroid and depression. In R.T. Joffe and A.J. Lewitt (Eds), The Thyroid Axis and Psychiatric Illness (pp.195-253) Washington, DC: American Psychiatric Press.
43. Joffe, R.T., Lewit, A. J. (2008). Basal thyrotropin and major depression: relation to clinical variables and treatment outcome. Can. J. Psychiatry. 53, 833-838.
44. Kennedy, J.A., Jarrett, D.B., Wellby, M.L. (1997). Influence of imipramine on the hypothalamic/pituitary/thyroid axis of the rat. Metabolism. 46, 1429-1434.
45. Kirkegaard, C., Faber, J., Hummer, L., Rogowski, P. (1979). Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology. 4:227-235.
46. Kirkegaard, C. (1981). The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology. 6, 189-212.
47. Kjellman, B.F., Beck-Friis, J., Ljunggren, J.G., Wetterberg, L. (1984). Twenty-four-hour serum levels of TSH in affective disorders. Acta Psychiatr. Scand. 69, 491-502.
48. König, F., Hauger, B., von Hippel, C., Wolfersdorf, M., Kaschka, W.P. (2000). Effect of paroxetine on thyroid hormone levels in severely depressed patients. Pharmacopsychiatry. 42, 135-138.
49. Kraemer, H.C., Frank, E., Kupfer, D.J. (2006). Moderators of treatment outcomes: clinical, research, and policy importance. JAMA. 296, 1286-1289.
50. Kusalic, M., Engelsmann, F., Bradwejn, J. (1993). Thyroid functioning during treatment for depression. J. Psychiatry Neurosci. 18, 260-263.
51. Langer, G., Koinig, G., Hatzinger, R., Schönbeck, G., Resch, F., Aschauer, H., Keshavan, M.S., Sieghart, W. (1986). Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Prediction of recovery and relapse in treatment with antidepressants and neuroleptics. Arch. Gen. Psychiatry. 43, 861-868.
52. Loosen, P.T., Prange, A.J.Jr., Wilson, I.C., Lara, P.P., Pettus, C. (1977). Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women. Psychoneuroendocrinology. 2, 137-148.
53. Loosen, P.T., Prange, A.J. (1982). Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am. J. Psychiatry. 139, 405-416.
54. Metz, C.E. (1978). Basic principles of ROC analysis. Semin. Nucl. Med. 8,283-298.
55. McEwen, B.S., Chattarji, S., Diamond, D.M., Jay, T.M., Reagan, L.P., Svenningsson, P., Fuchs, E. (2010). The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Molecular Psychiatry. 15, 237-249.
56. Mokrani, M.C., Duval, F., Monreal, Ortiz, J., Champeval, C., Maurice, D., Macher, J.P. (2006). Chronobiological HPT axis dysfunction in depression. Biol. Psychiatry. 59, 34S.
57. Rao, M.L., Ruhrmann, S., Retey, B., Liappis, N., Fuger, J., Kraemer, M., Kasper, S., Möller, H.J. (1996). Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry. 29, 180-186.
58. Rush, A.J., Wisniewski, S.R., Warden, D., Luther, J.F., Davis, L.L., Fava, M., Nierenberg, A.A., Trivedi, M.H. (2008). Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch. Gen. Psychiatry. 65, 870-880.
59. Sack, D.A., James, S.P., Rosenthal, N.E., Wehr, T.A. (1988). Deficient nocturnal surge of TSH during sleep and sle deprivation in rapid-cyclig bipolar illness. Psychiatry Res. 23(2), 179-191.
60. Sauvage, M.F., Marquet, P., Rousseau, A., Raby, C., Buxeraud, J., Lachâtre, G. (1998). Relationship between psychotropic drugs and thyroid function: a review. Toxicol. Appl. Pharmacol. 149, 127-135.
61. Schüle, C., Baghai, T.C., Alajbegovic, L., Schwarz, M., Zwanzger, P., Eser, D., Schaaf, L., Möller, H.J., Rupprecht, R. (2005). The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 255, 334-340.
62. Shelton, R.C., Winn, S., Ekhatore, N., Loosen, P.T. (1993). The effects of antidepressants on the thyroid axis in depression. Biol. Psychiatry. 33, 120-126.
63. Souêtre, E., Salvati, E., Pringuey, D., Krebs, B., Plasse, Y., Darcourt. G. (1986). The circadian rhythm of plasma thyrotropin in depression and recovery. Chronobiol. Int. 3, 197-205.
64. Spitzer, R.L., Endicott, J. (1975). Schedule for Affective Disorders and Schizophrenia, Lifetime Version. New York: Biometric Research Division, New York State Psychiatric Institute.
65. Stassen, H., Anghelescu, I.G., Angst, J., Böker, H., Lötscher, K., Rujescu, D., Szegedi, A., Scharfetter, C. (2011). Predicting response to psychopharmacological treatment: survey of recent results. Pharmacopsychiatry 44,263-272.
66. Sullivan, P.F., Wilson, D.A., Mulder, R.T., Joyce, P.R. (1997). The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatr. Scand. 95, 370-378.
67. Targum, S.D. (1983). The application of serial neuroendocrine challenge studies in the management of depressive disorder. Biol. Psychiatry. 18, 3-19.
68. Vanelle, J.M., Poirier, M.F., Benkelfat, C., Galinowski, A., Sechter, D., Suzini de Luca, H., Lôo, H. (1990). Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients. Acta Psychiatr. Scand. 81, 156-161.
69. Weeke, A., Weeke, J. (1980). The 24-hour pattern of serum TSH in patients with endogenous depression. Acta Psychiatr. Scand. 62, 69-74.
70. Whybrow, P.C., Prange, A.J. Jr. (1981). A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch. Gen. Psychiatry. 38, 106-113.
71. Widerlöv, E., Wide, L., Sjöström, R. (1978). Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin. Acta Psychiatr. Scand. 58, 449-456.